UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052638
Receipt number R000060064
Scientific Title Development of an application to connect infant mat-typed device and the effect of device use on reducing mothers' childrearing anxiety.
Date of disclosure of the study information 2023/10/27
Last modified on 2023/10/27 16:27:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of an application to connect infant mat-typed device and the effect of device use on reducing mothers' childrearing anxiety.

Acronym

Development of infant mat-typed device and connected application and their effectiveness in childrearing.

Scientific Title

Development of an application to connect infant mat-typed device and the effect of device use on reducing mothers' childrearing anxiety.

Scientific Title:Acronym

Development of infant mat-typed device and connected application and their effectiveness in childrearing.

Region

Japan


Condition

Condition

None

Classification by specialty

Nursing Adult Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to develop an infant mat-typed device capable of monitoring the biometric data and its connected application software and to verify their effectiveness in reducing mothers' childraring anxiety.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Mood Status

Key secondary outcomes

Depression, Quality of sleep


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Participants in the intervention group will use the developed mat-type device and linked app for one month.

Interventions/Control_2

Participants in the control group will not use the device and app.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1.Mothers raising 3-6 month-old children.
2. The Participants who have agreed to participate in this study.
3.The participants who attend all survey.

Key exclusion criteria

1. Mothers who do not live with their eligible children.
2.Mothers who are unable to participate in the survey because of the subject child's or their own illness.
3.Those who do not have sufficient ability in Japanese to participate in this survey.

Target sample size

48


Research contact person

Name of lead principal investigator

1st name Hiroko
Middle name
Last name Watanabe

Organization

Osaka University

Division name

Graduate School of Medicine, Health Science

Zip code

565-0871

Address

1-7 Yamadaoka, Suita, Osaka, Japan

TEL

06-6879-2520

Email

watanabe@sahs.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Hiroko
Middle name
Last name Watanabe

Organization

Osaka University

Division name

Graduate School of Medicine, Health Science

Zip code

565-0871

Address

1-7 Yamadaoka, Suita, Osaka, Japan

TEL

06-6879-2520

Homepage URL


Email

watanabe@sahs.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University

Institute

Department

Personal name



Funding Source

Organization

Osaka University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Aoyama Gakuin University, Kobe University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University Research Review Committee

Address

2-2 Yamadaoka, Suita, Osaka, Japan

Tel

06-6210-8289

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 10 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 10 Month 25 Day

Date of IRB


Anticipated trial start date

2023 Year 12 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 10 Month 27 Day

Last modified on

2023 Year 10 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060064